Skip to main content
TipRanks
Go Ultimate75% OFF

Fennec Pharmaceuticals (FENC) Revenue

266 Followers

Fennec Pharmaceuticals Revenue

Fennec Pharmaceuticals had a revenue of 17.87M in the quarter ending Jun 30, 2026, with 18.31%. This bring the company's revenue in the last twelve months to 59.22M, Increased 16.12%. In the fiscal year ending Dec 31, 2025, Fennec Pharmaceuticals had annual revenue of 44.64M with -6.09% growth.

Revenue (ttm)
59.22M
Revenue Growth
77.83%
P/S Ratio
8.31
Revenue/Employee
$1,275,486
Employees
35
Market Cap
$371.01M

Revenue Chart

Fennec Pharmaceuticals Revenue - Annual

010M20M30M40M50M170.00K1.53M21.25M47.54M44.64M201720182019202020212022202320242025
Revenue History
Download to Excel
FENC revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 202544.64M-2.90M-6.09%
Dec 31, 202447.54M26.29M123.69%
Dec 31, 202321.25M19.72M1284.50%
Dec 31, 20221.53M1.53M―
Dec 31, 20210.00-170.00K-100.00%
Dec 31, 2020170.00K170.00K―
Dec 31, 20190.000.00―
Dec 31, 20180.000.00―
Dec 31, 20170.00――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
FENC59.22M
TSE:MSCL0.00
TSE:HBP0.00
TSE:EPRX0.00
TSE:METX―